Sign up for free insights newsletter
60

Harbin Pharmaceutical Group Co Ltd

600664SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥4.17
-5.23%
End of day
Market Cap

$10.48B

P/E Ratio

23.11

Employees

10,180

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino8.6857.361.420.7211.06
Calmar69.401.730.617.94
Sharpe3.4121.740.760.424.33
Omega1.622.721.221.121.46
Martin3.231.212.11
Ulcer3.072.347.969.497.25

Harbin Pharmaceutical Group Co Ltd (600664) Price Performance

Harbin Pharmaceutical Group Co Ltd (600664) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY4.17, down 5.23% from the previous close.

Over the past year, 600664 has traded between a low of CNY3.31 and a high of CNY4.44. The stock has gained 12.1% over this period. It is currently 6.1% below its 52-week high.

Harbin Pharmaceutical Group Co Ltd has a market capitalization of $10.48B, with a price-to-earnings ratio of 23.11.

About Harbin Pharmaceutical Group Co Ltd

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese medicines, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, human erythropoietin injections, iron vitamin B12 oral solutions, ceftriaxone sodium injections, Qufenggutong gel cream, GNC Vitapak nutrition package, lacidipine tablets, GNC fish oil, GNC children's liquid calcium magnesium zinc IV, and penicillin and cephalosporin antibiotic preparations. The company sells its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, Puxue, Hayao, and Shiyitang brands. It is also involved in culture, science and technology, passenger transport, food, property, security, and pharmaceutical investment services, as well as biology and health technology activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.

Compare Harbin Pharmaceutical Group Co Ltd

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$15.94B
EBITDA
$770.89M
Profit Margin
2.82%
EPS (TTM)
0.18
Book Value
2.25

Technical Indicators

52 Week High
CN¥4.88
52 Week Low
CN¥3.23
50 Day MA
CN¥3.57
200 Day MA
CN¥3.67
Beta
0.19

Valuation

Trailing P/E
23.11
Forward P/E
20.16
Price/Sales
0.66
Price/Book
1.96
Enterprise Value
$9.59B